Why men with broken heart syndrome are more likely to die, according to experts
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Source: CNN
A 59-year-old man arrived at the Peking University First Hospital in Beijing for a procedure when he started having severe chest pain and shortness of breath.
Four months earlier, he had cancerous tumors removed from his bladder. Around his family, he tried his best to appear strong and avoided discussions of his health. Privately, his severe anxiety over the possibility of a cancer recurrence kept him awake at night.
Doctors said the man was experiencing takotsubo cardiomyopathy — also known as broken heart syndrome, as documented in a 2021 case study. The rare stress-induced heart condition has been observed primarily in women, but a study published in the Journal of the American Heart Association in May found that the illness may be more deadly for the men who get it.
Thought to be caused by extreme emotional or physical events — such as learning about the death of a loved one, winning the lottery or lifting a heavy sofa — takotsubo cardiomyopathy, or TC, occurs when the heart muscle is flooded with stress hormones, causing part of it to 'freeze' in place. As the heart struggles to properly pump blood, symptoms resemble those of a heart attack, including chest pain, heart palpitations and irregular heartbeat.
The new study analyzed data from nearly 200,000 patients hospitalized for TC in the United States between 2016 and 2020. While women accounted for 83% of the cases, men were more than twice as likely to die from the condition — with a mortality rate of 11.2%.
'The differences between men and women are a very striking finding,' said study coauthor Dr. Mohammad Reza Movahed, a clinical professor of medicine at the University of Arizona in Tucson. 'It raises a new, interesting question that should really be studied.'
Similar to differences between men's and women's cardiovascular health more generally, the discrepancies in TC death rates are not well understood, Movahed said, especially because they counter trends in other heart diseases. It's widely theorized, however, that differences in hormone levels play a role.
Stressful situations trigger the adrenal glands to release our fight-or-flight hormones, called catecholamines. They are meant to increase our blood pressure and raise our heart rate, but extreme levels can temporarily 'stun' cells in the heart's tissue, leading to TC, Movahed explained.
Men are thought to produce more catecholamines during stressful situations compared with women, possibly leading men to present with more severe cases of TC, he suggested.
Estrogen, a sex hormone produced at higher levels in women, may also have a protective effect on the cardiovascular system, making it easier to manage an extreme influx of catecholamines and reducing the risk of severe complications from TC, said Dr. Louis Vincent, a noninvasive-cardiology research fellow at the University of Miami, who coauthored a similar, multiyear study investigating discrepancies in men and women who had TC. Vincent was not involved in the new study.
Beyond biological differences, social factors may play a role as well.
'Most (physicians) know about takotsubo, but they may think of it as a disease just affecting women, so the diagnosis might be overlooked in men,' said Dr. Deepak Bhatt, a cardiologist and the director of Mount Sinai Fuster Heart Hospital who was not involved in the study. 'With misdiagnosis, care is delayed, and that can sometimes lead to worse outcomes.'
Men may also seek care at a later stage of illness, believing that their symptoms are manageable or may pass, said Dr. Alejandro Lemor, an assistant professor of interventional cardiology at the University of Mississippi Medical Center who was also not involved in the study.
Deadly complications from TC include blood clots, stroke, cardiac arrest and heart failure, Lemor said. If the condition is caught early, medications can reduce the risk of having these complications, restore proper heart function and allow for full recovery within weeks, he added.
Movahed's team was able to factor for important variables like age, race, income, chronic lung disease, hypertension and diabetes in the findings.
However, there was no patient data on other comorbid diseases, such as a history of stroke or the presence of a Covid-19 infection, Vincent said.
Additionally, the new study included in-patient diagnostic data only for those hospitalized with TC, so those who received outpatient care or died later from complications outside the hospital were likely not counted in the analysis, Movahed noted.
To establish a firmer explanation for the differences in mortality rates between men and women and further test treatment methods, a more detailed dataset would be needed, Vincent said.
'People should be aware in studies like this, we're presenting findings that are based on diagnostic codes, and we're not looking at patient procedures or lab results,' Vincent said. 'But it's powerful in the sense that it lets us look at large populations and look at trends. And I think that this trend of a higher mortality in men is worth taking a deeper look into.'
Sudden, severe chest pain or shortness of breath should always be treated as a medical emergency, warned Bhatt, who is also a professor of cardiovascular medicine at the Icahn School of Medicine at Mount Sinai in New York City.
'It's not a time to tough it out at home or get on the internet to figure it out. … Don't try to track down your primary care provider. Call emergency services,' Bhatt said. 'Time matters. By winning those few hours, you could save yourself irreparable damage to your heart.'
Symptoms following physical stressors — a common cause of TC in men — should not be ignored, Movahed said, especially preceding medical events such as asthma attacks, seizures or complications from drug use.
And while TC is caused by sudden stress, Bhatt said that managing chronic stress with daily meditation or exercise can lead to better cardiovascular health overall while giving you routines to fall back on in unexpected situations.
See Full Web Article
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
We came across a bullish thesis on Coherus BioSciences, Inc. (CHRS) on Steve Wagner's Substack. In this article, we will summarize the bulls' thesis on CHRS. Coherus BioSciences, Inc. (CHRS)'s share was trading at $0.77 as of 30th May. CHRS's trailing P/E was 1.77 according to Yahoo Finance. Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements. Coherus BioSciences (CHRS), long overlooked by Wall Street, is taking a bold step into innovative oncology by partnering with UK-based STORM Therapeutics to test a novel cancer treatment strategy. The collaboration brings together Coherus's immunotherapy toripalimab (LOQTORZI) and STORM's first-in-class RNA-modifying enzyme inhibitor STC-15 in a Phase 1b/2 clinical trial. This unexpected pairing represents a fresh approach to immuno-oncology, targeting cancer through dual mechanisms that could produce synergistic effects. Toripalimab, already approved in the U.S. for nasopharyngeal carcinoma and under review for broader indications, offers proven checkpoint inhibition, while STC-15 introduces a cutting-edge method of disrupting RNA methylation processes linked to tumor growth and immune evasion. If this combo demonstrates efficacy, it could represent a completely new class of cancer therapy and place Coherus at the forefront of next-generation immuno-oncology innovation. Importantly, this partnership shows strategic vision from CHRS's management as they seek to differentiate the company beyond biosimilars and move deeper into proprietary immunotherapy. With the trial still in early stages and little market attention so far, the risk/reward profile for investors is potentially skewed to the upside. Should the data prove positive, the impact could be significant for both companies, especially for CHRS as it repositions itself as a serious player in oncology innovation. This under-the-radar development deserves close monitoring, as it could catalyze a major reevaluation of Coherus's valuation and growth trajectory. Previously, we have covered CHRS in March 2025 wherein we summarized a by the same author. Coherus BioSciences (CHRS) posted a strong turnaround in 2024 with $267M in revenue and $28.5M net income, driven by Loqtorzi's growth and the planned $250M Udenyca divestiture. The company pivoted fully to oncology, trimmed costs, and advanced its pipeline, yet management expressed frustration over the stock's undervaluation, hinting at potential M&A. Since our last coverage, the stock is down 38% as of 30th May. We don't trust CHRS' management as the stock lost more than 95% of its value in recent years and is still losing a ton of money. The market agrees with us and thinks this stock is going to go bankrupt. We believe CHRS should stop wasting shareholder's money, sell valuable assets, and liquidate the company. We don't think that's a likely outcome. Coherus BioSciences, Inc. (CHRS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 10 hedge fund portfolios held CHRS at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of CHRS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CBS News
an hour ago
- CBS News
Botulism cases from Botox injections linked to Milton spa, health officials say
The Massachusetts Department of Public Health (DPH) has linked a Milton spa to a string of botulism cases from Botox injections. Ten people are suspected to have iatrogenic botulism, a rare but serious illness, after receiving a procedure at Rodrigo Beauty on Granite Avenue. Health officials advise that anyone who received Botox injections between May 1 and June 4 should contact their nearby health department or DPH. Iatrogenic botulism can happen when Botox spreads beyond where it was injected. Symptoms of iatrogenic botulism include blurred or double vision, slurred speech, breathing difficulties, drooping eyelids, and difficulty swallowing. Some more serious cases may experience progressive muscle weakness. If you experience any of these symptoms, the DPH recommends visiting the nearest emergency room. "Early recognition and treatment can significantly improve outcomes," the DPH said in a statement. The DPH asks that anyone contact them with questions or concerns at 617-983-6800. What is Botox? Cosmetic botulinum toxin, commonly referred to as Botox injections, is a "purified substance derived from bacteria," according to the American Society of Plastic Surgeons. It blocks the nerve signal to the muscle, which prevents the muscle from moving. It is commonly used to prevent wrinkles in the face. The Massachusetts DPH emphasizes that trained professionals should inject Botox and that the technique, use of non-FDA-approved products, and improper dosing increase the risk of botulism. Massachusetts spa owner arrested A Stoughton spa owner, with locations in Easton and Randolph, was arrested in November of 2024 for allegedly using illegal counterfeit Botox and filler injections. Thirty-eight-year-old Rebecca Fadanello allegedly performed thousands of injections using imported Botox, Sculptra, and Juvederm from China and Brazil. She purchased the products from Alibaba, a Chinese company that claims to sell products in bulk. She was charged with one count of illegally importing merchandise contrary to law, one count of selling or dispensing a counterfeit drug, and one count of selling or dispensing a counterfeit device.
Yahoo
3 hours ago
- Yahoo
Young People Are Getting Colon Cancer At An Alarming Rate. Here's The One Thing Experts Say Can Lower Your Risk.
Dense bean salads, which use beans as a salad base instead of lettuce, are all the rage on social media for good reason. The beans, along with the fresh veggies in the dish, help you reach your daily fiber goal, a number that experts say most Americans don't hit, which isn't good. Eating enough fiber is a crucial way to reduce your risk of colon cancer, a type of cancer that's on the rise in people 50 and younger in the US. (It's recommended that women eat roughly 25 grams of fiber each day while men consume about 38 grams, but most adults eat roughly 10 grams of fiber each day.) Decades ago, researchers found that people in Uganda had very low rates of colon cancer when compared to Americans because of their diet, which was high in fiber — veggies, fruits and grains — and low in meat, said Dr. Ron Quinton, the medical director of the Goldring Center for Culinary Medicine at Tulane University in New Orleans. Specifically, colon cancer occurred at a rate of 3.5 out of 100,000 in men in Uganda compared to 51.8 out of 100,000 in men in Connecticut. 'And I think that's the first time that it was really noticed that this was a prevention for colon cancer,' noted Quinton. Meaning, it's really important to prioritize your fiber consumption. There are multiple ways that fiber benefits colon health and even more ways to reach the daily recommended amount. Here's what experts say: Eating enough fiber helps move your stool through your digestive tract. 'Fiber plays an important role in the health of the colon, and when the colon gets unhealthy, then we're set up for development of cancer and other inflammatory diseases,' said Quinton. Overall, fiber adds bulk to the stool, which helps with proper colon function. '[Fiber] makes the stools more easy to move along, so the time that the stool spends in the colon is lessened, so less chance for constipation, more normal stools,' explained Quinton. This is also good for the removal of toxins: 'If there are any toxins in the stool that lead to cancer, they spend less time in the colon, and therefore lessen the chances of cancer exposure or other diseases,' he said. Fiber also benefits the microbiome, which is protective against colon cancer, too. Related: I'm Still Recovering From How Hard These 15 Women Made Me Laugh With Their Comedic Perfection This Week Fiber is also important for the microbiome, which has been the main focus of research in the past decade, said Mary Ellen Camire, a professor of food science and human nutrition at the University of Maine. Fiber is often prebiotic, meaning it's food for probiotic bacteria, Camire added. And probiotics help rebuild and balance your microbiome. 'When the bacteria get a nice fiber meal, they are very active, and they make compounds that help protect the colon' against colon cancer, along with other kinds of cancers, she explained. More, the cells that line the colon, which are called colonocytes, get their energy from the microbiome, added Quinton. 'And when the colonocytes are healthy, then they form an intact barrier along the colon, so that substances that may cause disease or cancer can't cross that barrier,' Quinton said. 'It also helps the colon produce mucus [and] thick mucus lining also protects the colon, so without enough fiber, our microbiome gets diseased and they don't produce the energy or nutrients that our colon needs to stay healthy,' he noted. Here's how you can eat more fiber: Related: 19 "Body Changes" That Clearly Indicate A Person Is Not Young Anymore, And I'm Not Ready For This Reality 'Fiber is a really critical part of our overall diet, and the typical American only gets 5 or 10% of the recommended amount of fiber in their diet on any given day,' said Quinton. As mentioned above, women need about 25 grams of fiber each day and men need about 38 grams, he said. Beans and legumes are very high in fiber and certain fruits and veggies are, too. Lentils have 18 grams of fiber per cup, black beans have about 15 grams in 1 can, chia seeds have 10 grams in 2 tablespoons, barley has 6 grams in 1 cup, raspberries have 8 grams in 1 cup and a pear has 6 grams, according to the Cleveland Clinic. This summer, you could make a bean and whole wheat pasta salad to up your fiber intake, or make some cold barley salads, said Camire. You can also lean into seasonal produce, she said. Camire added that it's important to spread your fiber intake out across the day and to consume different kinds of foods for fiber. 'The mistake a lot of people make when they decide 'I'm going to make fiber a priority' is they don't give their system time to adjust. If you're used to eating 15 grams of fiber a day, and you start eating 30 grams a day, the bacteria think they're having a party and so you may have some gas and cramping,' Camire said. You should start out gradually and slowly build up, she noted. 'Once you find the foods that you tolerate well and that you like, getting enough fiber won't be difficult or expensive,' Camire added. And fiber supplements don't cut it. It's tempting to turn to fiber supplements as a quick and easy way to reach your fiber goal, but experts say you shouldn't. 'None of the supplements ... are an adequate replacement for natural fiber,' Quinton said. Also, since you need so much fiber, fiber supplements end up being just a drop in the bucket, Camire added. While some of the supplements can increase your stool bulk and help constipation, 'they don't necessarily have the soluble fiber elements that feed the microbiome and keep it healthy, which keeps your gut healthy,' said Quinton. 'I don't think you can just replace the fiber with supplements. You need to be eating whole food,' Quinton added. Beyond fiber intake, there's more you can do to lower your colon cancer risk. It's important to also take other preventative steps to lower your risk of developing colon cancer. These include monitoring yourself for concerning symptoms such as ongoing stomach pain, blood in your stool or a change in your bowel movements. If you notice these symptoms, talk to your doctor. It's also important to let your doctor know if colon cancer runs in your family as you may be eligible for an early colonoscopy screening. Colonoscopy screenings start at 45 for those with no family history and without the symptoms mentioned above, but no matter when you're eligible, colonoscopies are the best way to screen for colon cancer and remove potentially precancerous polyps. 'During a colonoscopy, if we see a polyp, and we believe it to be the precancerous kind, which the vast majority are, we will remove those polyps at the colonoscopy,' Dr. Jeffrey Dueker, a gastroenterologist at UPMC and an associate professor of gastroenterology at the University of Pittsburgh School of Medicine, previously told HuffPost. 'And in doing so, we are reducing the colorectal cancer risk going forward,' Dueker added. With rising colon cancer rates in the U.S., it's important to do what you can to lessen your risk, which includes eating a high-fiber diet, going to necessary doctor's appointments and monitoring yourself for article originally appeared on HuffPost. Also in Goodful: 30 Absolutely Wild Medical Facts You've Probably Never Heard Of But Probably Should Hear Also in Goodful: 25 Life-Changing Habits People Added To Their Everyday Routines To Improve Their Lives For The Better Also in Goodful: "This Actually Isn't A Necessity": Millions Of People Watched A Mom Explain How Not Buying This Super Common Household Product Has Saved Her Family Thousands